The delivery to malignancy treatment presents stark variations between the United States and Continental Europe . Generally, US healthcare is characterized by a more reliance on for-profit insurance , https://bookmark-dofollow.com/story28136930/us-vs-continental-cancer-management-a-comparative-analysis